Novartis AG (NOTA)
TG
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 49.44B | 50.14B | 53.17B | 50.49B | 49.9B | 52.88B | 51.83B | 54.11B |
Operating Income | 8.97B | 9.74B | 14.61B | 9.82B | 10.83B | 27.03B | 9.19B | 10.02B |
Pre Tax Income | 7.82B | 9B | 13.84B | 9B | 9.88B | 26.14B | 8.37B | 9.33B |
Net Income | 6.71B | 7.7B | 12.61B | 11.73B | 8.07B | 24.02B | 6.96B | 14.85B |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 2.753 | 3.234 | 5.309 | 5.037 | 3.478 | 10.449 | 3.185 | 7.046 |
EBIT | 8.98B | 9.75B | 14.61B | 9.82B | 10.83B | 27.03B | 9.19B | 10.02B |
EBITDA | 15.03B | 15.85B | 21.34B | 15.68B | 17.3B | 33.24B | 16.38B | 18.31B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.